Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  ACB | T.ACB.WS.U

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Bullboard Posts
Comment by Pinotblancon Jan 14, 2019 10:38am
116 Views
Post# 29227462

RE:RE:RE:RE:PRE-MARKET SPIKED

RE:RE:RE:RE:PRE-MARKET SPIKED
JFR1611 wrote: Let's see how the market close before we pop the champagne on ACB...
just a reminder, the stock is down 47% versus its top in mid October...
my view here is very simple: cannabis is a commodity and the winners are those who have the lower cost of production. This is what the Canadian producers are missing. That's why I'm going to bet on Pharmacielo. On top of that, check who's sitting on their board. Very impressive for a $300M market cap company. Good luck anyway.


You are kidding again right? Calling the ACB management incompetent then popping the champagne after a day of trading? I do not care how the stock will close. If I was a day trader, I would. You seem to be new in the stock marget right? 

As for the second sentence I highlighted, you are completely wrong and I insist, very completely wrong. ACB will be a low cost producer, maybe not the lower, but it is irrelevant unless the price would be very high and it will not be the case. I will follow the company in my portfolio and I already read a bit about it but I keep ACB. 
Bullboard Posts